Table 3. Results of analyses of the association of candidate biomarkers with mortality among patients with advanced Chagas cardiomopathy (Stage D) using receiver operating characteristic curves and Cox regression models.
Crude model | Adjusted model2 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Biomarker | AUC1 | Cut-off1 (pg/ml) | Status | Median (IQR) biomarker level in pg/ml | N (%) above cutoff | P | HR1 (95% CI) | P | HR (95% CI) |
BNP3 | 0.61 | 184.1 | Alive | 109 (9-263) | 11 (37%) | 0.039 | 2.8 (1.1-7.2) | 0.025 | 3.1 (1.2-8.4) |
Died | 267 (37-347) | 14 (70%) | |||||||
NTproBNP3 | 0.66 | 765.1 | Alive | 425 (288-740) | 5 (16.7 %) | 0.002 | 4.1 (1.6-10.0) | 0.002 | 4.4 (1.8-11.0) |
Died | 777 (423-1310) | 11 (55%) | |||||||
CKMB3 | 0.56 | 8300 | Alive | 3994 (3447-7487) | 5 (17%) | 0.005 | 3.5 (1.6-8.5) | 0.009 | 3.3 (1.3-8.0) |
Died | 7534 (2960-11,438) | 10 (50%) | |||||||
MMP-23 | 0.72 | 103980 | Alive | 94,680 (75,549-111,884) | 9 (30%) | 0.008 | 4.0 (1.4-11.2) | 0.007 | 4.2 (1.5-11.8) |
Died | 126,828 (96,148-164,256) | 14 (74 %)4 |
Area under the curve (AUC), cutoffs and hazard ratios (HRs) based on receiver operating characteristic (ROC) curves. Hazard ratios were only calculated for those with AUC greater than 0.55.
Model adjusted for age and sex.
BNP, Brain Natriuretic Peptide; NTproBNP, N-terminal brain natriuretic peptide; CKMB, Creatine kinase-MB; MMP2, Matrix metalloproteinase 2.
MMP2 data were missing for one individual who died